3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with mecamylamine in 5 studies
Studies (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Trials (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Recent Studies (post-2010) (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Studies (mecamylamine) | Trials (mecamylamine) | Recent Studies (post-2010) (mecamylamine) |
---|---|---|---|---|---|
68 | 2 | 18 | 1,997 | 68 | 376 |
Protein | Taxonomy | 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (IC50) | mecamylamine (IC50) |
---|---|---|---|
Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.44 | |
Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | 2.0833 | |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | 1.6133 | |
Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 1.8 | |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.6 | |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens (human) | 3.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dart, MJ; Holladay, MW; Lynch, JK | 1 |
Arneric, SP; Brioni, JD; Brodie, MS; Decker, MW; Kim, DJ | 1 |
Holley, LA; Sarter, M; Turchi, J | 1 |
Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB | 1 |
Imoto, M; Ohno, T; Saito, K; Tani, Y; Tsuneyoshi, A | 1 |
1 review(s) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and mecamylamine
Article | Year |
---|---|
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
Topics: Acetylcholine; Animals; Binding Sites; Dopamine; Drug Design; Humans; Molecular Structure; Nervous System; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Structure-Activity Relationship | 1997 |
4 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and mecamylamine
Article | Year |
---|---|
ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Discrimination, Psychological; Dose-Response Relationship, Drug; Electrophysiology; Isoxazoles; Male; Mecamylamine; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Time Factors; Ventral Tegmental Area | 1995 |
Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.
Topics: Animals; Anti-Anxiety Agents; Arousal; Attention; Behavior, Animal; Isoxazoles; Ligands; Lobeline; Mecamylamine; Nicotine; Pyrrolidines; Rats; Receptors, Nicotinic; Time Factors | 1995 |
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1994 |
Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice.
Topics: Alkaloids; Animals; Azocines; Binding, Competitive; Brain; Dopamine; Isoxazoles; Male; Mecamylamine; Mice; Mice, Inbred Strains; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Pyrrolidines; Quinolizines; Serotonin; Tacrine | 1997 |